Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
66.5M
-
Shares change
-
+4.25M
-
Total reported value, excl. options
-
$1.37B
-
Value change
-
+$82.4M
-
Put/Call ratio
-
0.06
-
Number of buys
-
101
-
Number of sells
-
-69
-
Price
-
$20.66
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2015
195 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2015.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.5M shares
of 115M outstanding shares and own 57.73% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.47M shares), VANGUARD GROUP INC (4.62M shares), SYSTEMATIC FINANCIAL MANAGEMENT LP (4.15M shares), OAK RIDGE INVESTMENTS LLC (2.85M shares), Bank of New York Mellon Corp (2.21M shares), TimesSquare Capital Management, LLC (2.12M shares), Van Berkom & Associates Inc. (1.97M shares), KALMAR INVESTMENTS INC /DE/ (1.85M shares), BlackRock Fund Advisors (1.8M shares), and Champlain Investment Partners, LLC (1.79M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.